Zurcher Kantonalbank (Zurich Cantonalbank) - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 173 filers reported holding ACCELERON PHARMA INC in Q3 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$1,039,000
+37.4%
6,036
+0.2%
0.01%
+50.0%
Q2 2021$756,000
-7.1%
6,021
+0.3%
0.00%
-20.0%
Q1 2021$814,000
-7.2%
6,001
-12.4%
0.01%0.0%
Q4 2020$877,000
+43.1%
6,853
+25.9%
0.01%
+25.0%
Q3 2020$613,000
+18.1%
5,4430.0%0.00%0.0%
Q2 2020$519,000
+56.3%
5,443
+47.5%
0.00%
+33.3%
Q1 2020$332,000
+87.6%
3,690
+10.7%
0.00%
+200.0%
Q4 2019$177,000
+51.3%
3,333
+12.7%
0.00%0.0%
Q3 2019$117,000
-4.1%
2,9580.0%0.00%0.0%
Q2 2019$122,000
-11.6%
2,9580.0%0.00%0.0%
Q1 2019$138,000
+22.1%
2,958
+13.7%
0.00%0.0%
Q4 2018$113,000
-11.0%
2,602
+17.4%
0.00%0.0%
Q3 2018$127,000
+60.8%
2,216
+36.1%
0.00%0.0%
Q2 2018$79,000
+23.4%
1,6280.0%0.00%0.0%
Q1 2018$64,000
-7.2%
1,6280.0%0.00%0.0%
Q4 2017$69,000
+81.6%
1,628
+59.0%
0.00%
Q3 2017$38,000
+22.6%
1,0240.0%0.00%
Q2 2017$31,000
+14.8%
1,0240.0%0.00%
Q1 2017$27,000
+3.8%
1,0240.0%0.00%
Q4 2016$26,000
-29.7%
1,0240.0%0.00%
Q3 2016$37,000
+32.1%
1,024
+23.8%
0.00%
Q2 2016$28,000
+27.3%
8270.0%0.00%
Q1 2016$22,000
-45.0%
8270.0%0.00%
-100.0%
Q4 2015$40,000
+471.4%
827
+188.2%
0.00%
Q3 2015$7,0002870.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2018
NameSharesValueWeighting ↓
Artal Group S.A. 1,400,000$133,378,0003.73%
Foresite Capital Management III, LLC 42,030$4,004,0003.56%
KINGDON CAPITAL MANAGEMENT, L.L.C. 257,249$24,508,0002.23%
Cormorant Asset Management, LP 600,000$57,162,0002.18%
Avoro Capital Advisors LLC 1,040,000$99,081,0001.96%
QVT Financial LP 101,396$9,660,0001.64%
FARALLON CAPITAL MANAGEMENT LLC 2,100,000$200,067,0001.60%
Rhenman & Partners Asset Management AB 155,000$14,767,0001.60%
Parkman Healthcare Partners LLC 57,500$5,478,0001.54%
Ikarian Capital, LLC 187,700$17,882,0001.42%
View complete list of ACCELERON PHARMA INC shareholders